The current leadership team at Merz Pharma has a history of experience in the pharmaceutical industry. The team includes the CEO of Merz Therapeutics, the Country Manager of Nycomed Germany Holding, and the BU-Leiter of Sanofi-Aventis Deutschland GmbH. The team also has a background in Gesundheitsökonomie und Controlling from Aventis Pharma Deutschland GmbH.
View all